Medeze Commended by Frost & Sullivan for Dominating the Stem Cell Banking Market with Its Pioneering, Full Spectrum Services
SINGAPORE, March 12, 2021 /PRNewswire/ --Based on its recent analysis of the Southeast Asia stem cell banking market, Frost & Sullivan recognizes Medeze Group with the 2020 Southeast Asia Stem Cell Banking Technology Innovation Leadership Award and the 2020 Thai Stem Cell Banking Company of the Year Award.
- SINGAPORE, March 12, 2021 /PRNewswire/ --Based on its recent analysis of the Southeast Asia stem cell banking market, Frost & Sullivan recognizes Medeze Group with the 2020 Southeast Asia Stem Cell Banking Technology Innovation Leadership Award and the 2020 Thai Stem Cell Banking Company of the Year Award.
- Medeze has launched numerous first-to-market solutions in the Southeast Asian market and has maintained its leadership position in the Thai market with more than a 60% market share.
- "Medeze was the first stem cell banking company in Thailand to bank mesenchymal stem cells (MSC) derived from placenta, cord tissue, and adipose tissue.
- On top of being Thailand's largest and most experienced MSC bank, Medeze offers cord blood banking, cord tissue banking, and adipose tissue banking.